Filter
953
Filtered Results: 953
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
79
New Publications
285
Language
Document type
No document type
481
Studies & Reports
176
Guidelines
144
Manuals
59
Strategic & Response Plan
56
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
Global
25
South Africa
24
Ghana
21
Liberia
21
Nigeria
20
Namibia
20
Rwanda
18
Tanzania
18
Sierra Leone
16
Bangladesh
16
Zambia
16
Malawi
15
Nepal
14
Western and Central Europe
14
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
South–East Asia Region
6
Latin America and the Carribbean
5
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
425
Clinical Guidelines
57
Key Resources
36
Public Health
34
Pharmacy & Technologies
29
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
124
Pharmacy
117
COVID-19
54
TB
40
HIV
39
Rapid Response
34
Mental Health
31
Global Health Education
20
Planetary Health
19
Ebola & Marburg
14
Caregiver
14
NTDs
14
Conflict
14
Health Financing Toolbox
13
Malaria
11
Specific Hazards
10
NCDs
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
2.0 Rapid Response
2
Zika
2
Social Ethics
1
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
Planned and regulated task shifting and task sharing can have a range of benefits. It can ensure a rational optimization of the available health workforce, address health system shortages of specialized health-care professionals, improve equity in access to health care and increase the acceptability...
J of Pharm Policy and Pract 14, 27 (2021). https://doi.org/10.1186/s40545-021-00309-8
Towards a Healthier Botswana
